EWTX |
Edgewise Therapeutics, Inc. |
Sep 20, 2024 |
6 |
-$1.95M |
4 |
Sep 24, 2024 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Aug 12, 2024 |
2 |
$0 |
4 |
Aug 14, 2024 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
May 1, 2024 |
3 |
-$37K |
4 |
May 3, 2024 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Feb 7, 2024 |
9 |
-$539K |
4 |
Feb 9, 2024 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Dec 27, 2023 |
1 |
-$89.2K |
4 |
Dec 28, 2023 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Aug 17, 2023 |
1 |
$0 |
4 |
Aug 18, 2023 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
May 1, 2023 |
3 |
-$16.9K |
4 |
May 3, 2023 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Oct 3, 2022 |
3 |
-$37K |
4 |
Oct 5, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Sep 6, 2022 |
4 |
-$42.5K |
4 |
Sep 8, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Aug 8, 2022 |
1 |
$0 |
4 |
Aug 10, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Aug 3, 2022 |
5 |
-$73.6K |
4 |
Aug 5, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Jul 5, 2022 |
8 |
-$64.9K |
4 |
Jul 7, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Jun 16, 2022 |
11 |
-$349K |
4 |
Jun 21, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Jun 13, 2022 |
12 |
-$141K |
4 |
Jun 15, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Jun 8, 2022 |
9 |
-$156K |
4 |
Jun 10, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Jun 3, 2022 |
12 |
-$226K |
4 |
Jun 7, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
May 16, 2022 |
1 |
-$80.1K |
4 |
May 18, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
May 1, 2022 |
1 |
$0 |
4 |
May 3, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Jan 21, 2022 |
2 |
$3.83K |
4 |
Jan 25, 2022 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Dec 28, 2021 |
2 |
$3.83K |
4 |
Dec 30, 2021 |
General Counsel |
EWTX |
Edgewise Therapeutics, Inc. |
Aug 17, 2021 |
1 |
$0 |
4 |
Aug 19, 2021 |
General Counsel |